Continuous co-administration of dextromethorphan or MK-801 with morphine: Attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance

Pain

Volumn 67, Issue 1, 1996, Pages 79-88

  Manning, Barton H ^a   Mao, Jianren ^a   Frenk, Hanan ^b   Price, Donald D ^a   Mayer, David J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antinociception; Dextromethorphan; MK 801; Morphine dependence; Morphine tolerance; N Methyl D aspartate receptor antagonists

Indexed keywords

DEXTROMETHORPHAN; DIZOCILPINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG TOLERANCE; DRUG TOXICITY; DRUG WITHDRAWAL; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030248211     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)81972-5     Document Type: Article

References (34)

1. Ben-Eliyahu S., Marek P., Vaccarino A.L., Mogil J.S., Sternberg W.F., Liebeskind J.C. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575:1992;304-308.
2. Bhargava H.N., Matwyshyn G.A. Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology. 47:1993;344-350.
3. 3H]-MK-801 binding sites in mammalian brain. Br. J. Pharmacol. 93:1988;944-954.
4. 3H]dextromethorphan in guinea pig brain: allosteric enhancement by ropizine. J. Neurosci. Res. 24:1989;311-328.
5. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
6. Depaulis A., Morgan M.M., Liebeskind J.C. GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat. Brain Res. 436:1987;223-228.
7. Elliott K., Minami N., Kolesnikov Y.A., Pasternak G.W., Inturrisi C.E. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain. 56:1994;69-75.
8. Elliott K., Hynansky A., Inturrisi C.E. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain. 59:1994;361-368.
9. Fundytus M.E., Coderre T.J. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. Br. J. Pharmacol. 113:1994;1215-1220.
10. Gutstein H.B., Trujillo K.A. MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res. 626:1993;332-334.
11. Kissin I., Brown P.T., Robinson C.A., Bradley E.L. Jr. Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology. 74:1991;166-171.
12. Kuribara H., Asami T., Ida I., Tadokoro S. Characteristics of the ambulation-increasing effect of the noncompetitive NMDA antagonist MK-801 in mice: assessment by the coadministration with central-acting drugs. Jpn. J. Pharmacol. 58:1992;11-18.
13. Lipa S.M., Kavaliers M. Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res. Bull. 24:1990;627-630.
14. Lutfy K., Hurlbut D.E., Weber E. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616:1993;83-88.
15. Lutfy K., Shen K.-Z., Kwon I.-S., Cai S.X., Woodward R.M., Keana J.F.W., Weber E. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur. J. Pharmacol. 273:1995;187-189.
16. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14:1994;2301-2312.
17. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
18. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 61:1995;353-364.
19. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
20. Marek P., Ben-Eliyahu S., Vaccarino A.L., Liebeskind J.C. Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558:1991;163-165.
21. 2+ in mammalian neurons. Trends Pharmacol. Sci. 11:1990;254-260.
22. Musacchio J.M., Klein M. Dextromethorphan binding sites in the guinea pig brain. Cell. Mol. Neurobiol. 8:1988;149-156.
23. Netzer R., Pflimlin P., Trube G. Dextromethorphan blocks N-methyl- D-aspartate-induced currents in cultured cortical neurons. Eur. J. Pharmacol. 238:1993;209-216.
24. 2 receptor blockade on MK-801 - induced hyperlocomotion in rats. Psychopharmacology. 111:1993;427-434.
25. Rasmussen K., Fuller R.W., Stockton M.E., Perry K.W., Swinford R.M., Ornstein P.L. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmacol. 197:1991;9-16.
26. 3H]MK-801 binding sites determined by quantitative autoradiography in rat brain. Neuroscience. 40:1991;533-543.
27. Sommer B., Seeburg P.H. Glutamate receptor channels: novel properties and new clones. Trends Pharmacol. Sci. 13:1992;291-296.
28. Tanganelli S., Antonelli T., Morari M., Bianchi C., Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122:1991;270-272.
29. Tiseo P.J., Cheng J., Pasternak G.W., Inturrisi C.E. Modulation of morphine tolerance by the competitive N-methyl- D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes. J. Pharmacol. Exp. Ther. 268:1994;195-201.
30. Tiseo P.J., Inturrisi C.E. Attenuation and reversal of morphine tolerance by the competitive N-methyl- D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. 264:1993;1090-1096.
31. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
32. Trujillo K.A., Akil H. Inhibition of opiate tolerance by non-competitive N-methyl- D-aspartate receptor antagonists. Brain Res. 633:1994;178-188.
33. Trujillo K.A., Akil H. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality. Pharmacol. Biochem. Behav. 38:1991;673-675.
34. Wei E.T. Enkephalin analogs and physical dependence. J. Pharmacol. Exp. Ther. 216:1981;12-18.